SCHEMBL24601430

SCHEMBL24601430

c1ccc(-c2cccc(-c3ccccc3)c2-c2ccc3c(c2)c2c4c5ccccc5n5c6ccc(-c7c(-c8ccccc8)cccc7-c7ccccc7)cc6c(c6c7ccccc7n3c62)c45)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.36
TSPO P30536 1/20 0.33
HTR6 P50406 2/20 0.33
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
RECQL P46063 1/20 0.32
KMT2A Q03164 1/20 0.32
PLEC Q15149 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CHEK1 O14757 2/20 0.32
WEE1 P30291 2/20 0.32
MAPK14 Q16539 1/20 0.31
FLT3 P36888 1/20 0.31
BMX P51813 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
RET P07949 1/20 0.31
MAP4K4 O95819 1/20 0.30
CSF1R P07333 1/20 0.30
FGFR1 P11362 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601649 1.00 HSD17B10 (0.36) HSD17B10TSPOHTR6KDM4EMEN1
SCHEMBL24601509 0.97 HSD17B10 (0.34) HSD17B10TSPOHTR6KDM4EMEN1
SCHEMBL24601624 0.93 HSD17B10 (0.35) HSD17B10HTR6KDM4EMEN1MAPT
SCHEMBL24601423 0.93 HSD17B10 (0.35) HSD17B10HTR6KDM4EMEN1MAPT
SCHEMBL24601522 0.93 F9 (0.32) KDM4EMEN1MAPTRECQLKMT2A
SCHEMBL22178583 0.91 HSD17B10 (0.37) HSD17B10TSPOHTR6KDM4EMEN1
SCHEMBL24601519 0.90 MAOB (0.35) TSPOKDM4EMEN1MAPTRECQL
SCHEMBL24601501 0.90 MAOB (0.35) TSPOKDM4EMEN1MAPTRECQL
SCHEMBL24601497 0.90 HSD17B10 (0.35) HSD17B10HTR6KDM4EMEN1MAPT
SCHEMBL24601804 0.90 TSPO (0.35) HSD17B10TSPOHTR6CHEK1WEE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 HSD17B10 4661/4885TSPO 3404/4885HTR6 3265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.